By Mike Cherney
In the race to tap bond investors for cash, Medtronic Inc. has
outdone Apple Inc. and Alibaba Group Holding Ltd.
The Minneapolis medical-device maker completed the largest
corporate-debt sale of the year Monday, raising $17 billion in a
deal that underscores the booming investor appetite for highly
rated bonds. The sale will enable the company to finance its $43
billion purchase of Ireland's Covidien PLC in a transaction
structured as a so-called inversion, a type of deal that affords
tax benefits but recently came under fire from U.S. policy
makers.
The Medtronic bond sale brings issuance so far this year to
roughly $1.5 trillion, putting 2014 on pace to be the third record
year in a row, according to data provider Dealogic. The figure
includes sales of debt of all ratings in the U.S.
This year's biggest corporate-bond deal had been Apple's $12
billion sale in April. Medtronic also topped Alibaba's $8 billion
offering last month.
The pace of bond sales shows little sign of abating. Internet
retailer Amazon.com Inc. indicated that it plans to sell bonds on
Tuesday, its first deal in two years. No size was given.
Companies are borrowing at a hectic clip to take advantage of
low interest rates and are using the cash to finance everything
from mergers and acquisitions to share buybacks. The size of the
Medtronic bond deal was bigger than some market watchers expected,
a sign that investors are scrambling to snap up relatively safe
debt that offers higher yields than Treasurys and other
developed-country government bonds.
Highly rated U.S. corporate debt has been among the
best-performing categories of fixed income so far this year as
global growth concerns have kept bond yields broadly subdued.
Yields on the Medtronic bonds were lowered throughout the day,
an indication of strong investor demand. A 10-year bond was
initially offered to yield roughly 1.55 percentage points more than
benchmark Treasurys, but was priced at a spread of 1.40 percentage
points, for a total yield of 3.613%. The company sold bonds of
maturities between three and 30 years.
The bond sale attracted $45 billion in orders, according to a
person with knowledge of the process.
"The cost of financing is attractive for corporations," said
Jerry Cudzil, head of U.S. credit trading at TCW, which oversees
$155 billion and put in an order for the Medtronic bonds. "What
this tells you is that the market remains fairly open."
Some investors said they bought the Medtronic bonds because the
debt offered greater yield than the company's outstanding bonds.
Money managers also said they believed the acquisition of Covidien,
which also makes medical devices, would benefit Medtronic over the
longer term. The bond sale was led by Bank of America Merrill
Lynch, Deutsche Bank AG and J.P. Morgan Chase & Co.
The bonds were given a provisional rating of A3 by Moody's
Investors Service, one notch below where the company was previously
rated, but still well within investment grade.
"We see a pretty significant upside in this if you look at other
A-rated names in health care" and pharmaceuticals, said Bert
Zimmerman, senior fixed income analyst at Principal Global
Investors, which oversees about $322 billion and put in an order
for the Medtronic bonds.
Medtronic, which struck the deal to take over Covidien in June,
previously said it planned to use $13.5 billion in cash held by its
foreign subsidiaries. However, a tax-rule change made by the Obama
administration in September made it more costly for Medtronic to
access that cash, prompting the firm to turn to U.S. credit markets
instead.
Medtronic has said it plans to switch its domicile to Ireland
after the takeover is completed to take advantage of lower
corporate-tax rates overseas.
Other big corporate-bond sales this year came from French cable
operator Numericable Group, which in April sold $10.9 billion in
debt, and Oracle Corp. which sold $10 billion in June. The largest
corporate-bond sale on record came in September 2013, when Verizon
Communications Inc. sold $49 billion.
In April 2013, Apple sold $17 billion, which is now tied with
Medtronic for the second largest.
Write to Mike Cherney at mike.cherney@wsj.com
Access Investor Kit for Covidien Plc
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=IE00B68SQD29
Access Investor Kit for Amazon.com, Inc.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US0231351067
Access Investor Kit for Apple, Inc.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US0378331005
Access Investor Kit for JPMorgan Chase & Co.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US46625H1005
Access Investor Kit for Medtronic, Inc.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US5850551061
Access Investor Kit for Oracle Corp.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US68389X1054
Access Investor Kit for Verizon Communications, Inc.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US92343V1044